1 |
Beechinor R, Palumbo A, Chew H, Arora M. Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. ESMO Open 2022;7:100393. [DOI: 10.1016/j.esmoop.2022.100393] [Reference Citation Analysis]
|
2 |
Kim SY, Lee CH, Min C, Yoo DM, Choi HG. Association between Proton Pump Inhibitors and Hearing Impairment: A Nested Case-Control Study. Curr Issues Mol Biol 2021;43:142-52. [PMID: 34070082 DOI: 10.3390/cimb43010012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Sarnaik MK, Modi S, Pisipati Y, Vaidya S, Syed Gaggatur N, Sange AH, Srinivas N, Sange I. Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol. Cureus 2021;13:e16744. [PMID: 34354892 DOI: 10.7759/cureus.16744] [Reference Citation Analysis]
|
4 |
Franciosi JP, Mougey EB, Dellon ES, Gutierrez-junquera C, Fernandez-fernandez S, Venkatesh RD, Gupta SK. Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions. JAA 2022;Volume 15:281-302. [DOI: 10.2147/jaa.s274524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|